(Q38480790)

3 September 2017

title

How close is evidence to truth in evidence-based treatment of mental disorders? (English)

1 reference

3 September 2017

1

Hans-Jürgen Möller

1 reference

3 September 2017

publication date

22 November 2011

1 reference

3 September 2017

number of pages

13

1 reference

European Archives of Psychiatry and Clinical Neuroscience

inferred from page(s)

published in

1 reference

3 September 2017

volume

262

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

277-289

1 reference

Placebo-controlled studies in depression: necessary, ethical and feasible

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

How to grade categories of evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthre

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Psychosocial interventions for the prevention of relapse in bipolar disorder: systematic review of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Framework for design and evaluation of complex interventions to improve health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

A meta-analysis of the efficacy of second-generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Research designs for studies evaluating the effectiveness of change and improvement strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Design of clinical trials of antidepressants: should a placebo control arm be included?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Should combined pharmaco- and psychotherapy be offered to depressed patients? A qualitative review of randomized clinical trials from the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Meta-analysis: fact or fiction? How to interpret meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Methodology and Reports of Systematic Reviews and Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Flawed Meta-Analyses Comparing Psychotherapy With Pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Two-Year Randomized Controlled Trial and Follow-up of Dialectical Behavior Therapy vs Therapy by Experts for Suicidal Behaviors and Borderline Personality Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Rating the strength of scientific evidence: relevance for quality improvement programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Methodological issues in psychiatry: psychiatry as an empirical science

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Do effectiveness ("real world") studies on antipsychotics tell us the real truth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Isn't the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Is evidence sufficient for evidence-based medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Principle standards and problems regarding proof of efficacy in clinical psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Evidence based medicine: what it is and what it isn't

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

A meta-(re)analysis of the effects of cognitive therapy versus 'other therapies' for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0273-8

Day centres for severe mental illness.

21 January 2018

1 reference

12 December 2020

Evidence-based medicine and 'The Cochrane Collaboration'

1 reference

12 December 2020

Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression

1 reference

12 December 2020

[Evidence-based medicine. How to use biomedical literature to solve clinical problems. Italian Group on Evidence-Based Medicine-GIMBE]

1 reference

12 December 2020

How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials?

1 reference

12 December 2020

Metaanalyses - highest level of empirical evidence?

1 reference

12 December 2020

Evidence-based medicine: useful tools for decision making

1 reference

12 December 2020

[Evidence-based medicine. 3. Systematic reviews: a tool for clinical practice, permanent education and health policy decisions. Italian Group on Evidence-Based Medicine-GIMBE]

1 reference

12 December 2020

[Evidence-based medicine and psychotherapy: what are adequate research methods?]

1 reference

12 December 2020

Case management for people with severe mental disorders

1 reference

12 December 2020

Grading quality of evidence and strength of recommendations

1 reference

12 December 2020

Developing and implementing clinical guidelines: lessons from the NICE schizophrenia guideline

1 reference

12 December 2020

Evidence-based treatment for first-episode schizophrenia?

1 reference

12 December 2020

The evidence base of clinical practice guidelines, health technology assessments and patient information as a basis for clinical decision-making

1 reference

12 December 2020

Day hospital versus admission for acute psychiatric disorders

1 reference

12 December 2020

[Is mental health services research in need of randomised controlled trials?]

1 reference

12 December 2020

Medicare and medical technology--the growing demand for relevant outcomes

1 reference

12 December 2020

Pharmacological and psychological treatments for depressed older patients: a meta-analysis and overview of recent findings

1 reference

12 December 2020

[From evidence-based medicine to medicine-based evidence]

1 reference

12 December 2020

Supported housing for people with severe mental disorders.

1 reference

12 December 2020

Meta-analyses: a method to maximise the evidence from clinical studies?

1 reference

12 December 2020

What is evidence-based medicine and the role of the systematic review: the revolution coming your way.

1 reference

12 December 2020

Placebo, prozac and PLoS: significant lessons for psychopharmacology

1 reference

12 December 2020

Giving teeth to comparative-effectiveness research--the Oregon experience

1 reference

12 December 2020

10.1007/S00406-011-0273-8

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1010557763

0 references

1 reference